Remove Article 2021 12 16 Data-transformation-helping-adverse-event-case-processing
article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

With the sector looking strong it would be easy to think of the cell & gene sector as being resilient to challenge but this is never the case in pharma: fierce competition can result in fluctuating valuations for listed companies and the regulatory hurdles of pharma means that many companies won’t ever see their product reach the bedside. .

article thumbnail

Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data

XTalks

This article serves as a resource for healthcare professionals, life sciences researchers and industry enthusiasts seeking to stay informed of the latest developments and success stories in oncology therapeutics. Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 40 Best-Selling Cancer Drugs in 2023 by 2022 Data

XTalks

This article serves as a resource for healthcare professionals, life sciences researchers and industry enthusiasts seeking to stay informed of the latest developments and success stories in oncology therapeutics. Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

Unlike other candidate vaccines, CoronaVac is an inactivated whole virus vaccine developed through the same process as has long been used to make influenza vaccines, among many others. The US continues to lead the world in the number of confirmed cases at over four million while the number of deaths is now approaching 150,000.